Trials / Unknown
UnknownNCT01302912
Lymphoma in the Orbit
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Imaging techniques have considerably improved over the last decades and ocular adnexal lymphomas (OALs) nowadays can be detected. As major advances in immunophenotyping and molecular diagnostics in histology have been achieved offering an accurate diagnosis, the investigators would like to introduce that surgical biopsy of an orbital lymphoma becomes crucial for the possibility of a correct diagnosis and proper treatment. As radiotherapy accomplished great preciseness as well and OALs respond excellently to radiation, this therapy should be the treatment of choice in local defined lymphomas instead of blind treatment with steroids. Radiation results in great local control rates of 85% to 100% * Trial with surgical intervention
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lymphoma-Biopsy | Patients after biopsy of orbital lymphoma |
Timeline
- Start date
- 2011-02-01
- Completion
- 2012-05-01
- First posted
- 2011-02-24
- Last updated
- 2011-11-04
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01302912. Inclusion in this directory is not an endorsement.